The Patent Finder

Union Therapeutics A/S

Also on record
Records under this name other than the patents Union Therapeutics A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.

Back to Union Therapeutics A/S

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,758,553Antibacterial use of halogenated salicylanilides
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,384,096Substituted Azetidine Dihydrothienopyridines and Their Use as Phosphodiesterase Inhibitors
Lapsed on the fee record
Ended Jul 12, 2026 · High confidence
Lapsed on the fee recordEnded Jul 12, 2026High confidence
US 11,365,204Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
Lapsed on the fee record
Ended Jun 21, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 21, 2026USPTO record
US 11,331,289Antimicrobial composition
Lapsed on the fee record
Ended May 17, 2026 · USPTO record
Lapsed on the fee recordEnded May 17, 2026USPTO record
US 11,331,327Antibacterial use of halogenated salicylanilides
Lapsed on the fee record
Ended May 17, 2026 · USPTO record
Lapsed on the fee recordEnded May 17, 2026USPTO record
US 11,324,708Niclosamide formulations for treating disease
Lapsed on the fee record
Ended May 10, 2026 · USPTO record
Lapsed on the fee recordEnded May 10, 2026USPTO record
US 11,324,761Antibacterial use of halogenated salicylanilides
Lapsed on the fee record
Ended May 10, 2026 · USPTO record
Lapsed on the fee recordEnded May 10, 2026USPTO record
US 9,949,988Antibacterial use of halogenated salicylanilides
Lapsed on the fee record
Ended Apr 24, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 24, 2026USPTO record
US 11,285,164Antibacterial use of halogenated salicylanilides
Lapsed on the fee record
Ended Mar 29, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 29, 2026USPTO record
US 11,213,533Combinations comprising dibromopropamidine or diminazene and a tetracycline anti-bacterial agent
Lapsed on the fee record
Ended Jan 4, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 4, 2026USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited